Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015, Article ID 674175, 12 pages
http://dx.doi.org/10.1155/2015/674175
Research Article

Optimization and Characterization of Artesunate-Loaded Chitosan-Decorated Poly(D,L-lactide-co-glycolide) Acid Nanoparticles

1National Institute of Pharmaceutical Technology, Hanoi University of Pharmacy, 13-15 Le Thanh Tong, Hoan Kiem, Ha Noi 100000, Vietnam
2Hue College of Medicine and Pharmacy, Hue University, 6 Ngo Quyen, Hue, Thua Thien Hue 530000, Vietnam
3College of Pharmacy, Yeungnam University, 214-1 Dae-Dong, Gyeongsan 712-749, Republic of Korea

Received 4 September 2015; Accepted 3 November 2015

Academic Editor: Ilaria Armentano

Copyright © 2015 Hoang Nhan Ho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Hamacher-Brady, H. A. Stein, S. Turschner et al., “Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production,” The Journal of Biological Chemistry, vol. 286, no. 8, pp. 6587–6601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. Crespo-Ortiz and M. Q. Wei, “Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 247597, 18 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Efferth, A. Sauerbrey, A. Olbrich et al., “Molecular modes of action of artesunate in tumor cell lines,” Molecular Pharmacology, vol. 64, no. 2, pp. 382–394, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. K. T. Batty, K. F. Ilett, M. E. Davis, and Timothy, “Chemical stability of artesunate injection and proposal for its administration by intravenous infusion,” Journal of Pharmacy and Pharmacology, vol. 48, no. 1, pp. 22–26, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Durán, P. D. Marcato, Z. Teixeira, M. Durán, F. T. M. Costa, and M. Brocchi, “State of the art of nanobiotechnology applications in neglected diseases,” Current Nanoscience, vol. 5, no. 4, pp. 396–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Danhier, E. Ansorena, J. M. Silva, R. Coco, A. Le Breton, and V. Préat, “PLGA-based nanoparticles: an overview of biomedical applications,” Journal of Controlled Release, vol. 161, no. 2, pp. 505–522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. H. K. Makadia and S. J. Siegel, “Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier,” Polymers, vol. 3, no. 3, pp. 1377–1397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. T. Nguyen, T. H. Tran, J. O. Kim, C. S. Yong, and C. N. Nguyen, “Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles,” Archives of Pharmacal Research, vol. 38, no. 5, pp. 716–724, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Wang, P. Li, and L. Kong, “Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery,” AAPS PharmSciTech, vol. 14, no. 2, pp. 585–592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H.-L. Chen, Y.-X. Wang, P. Zhou et al., “Chitosan surface-modified PLGA nanoparticles: preparation, characterization, and evaluation of their in vitro drug-release behaviors and cytotoxicities,” Current Nanoscience, vol. 10, no. 2, pp. 255–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. V. Date, A. Samad, and P. V. Devarajan, “Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying,” AAPS PharmSciTech, vol. 11, no. 1, pp. 304–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Abdel-Hafez, R. M. Hathout, and O. A. Sammour, “Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs,” International Journal of Biological Macromolecules, vol. 64, pp. 334–340, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. D. C. Montgomery, Design and Analysis of Experiments, John Wiley & Sons, 8th edition, 2012.
  14. C. Nguyen, J. M. Christensen, and T. Nguyen, “Application of D-optimal study design with contour surface response for designing sustained release gliclazide matrix tablets,” Pharmacology & Pharmacy, vol. 5, no. 7, pp. 620–635, 2014. View at Publisher · View at Google Scholar
  15. T. H. Tran, T. Ramasamy, H. J. Cho et al., “Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability,” Journal of Nanoscience and Nanotechnology, vol. 14, no. 7, pp. 4820–4831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Ramasamy, T. H. Tran, H. J. Cho et al., “Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization,” Pharmaceutical Research, vol. 31, no. 5, pp. 1302–1314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Wang, Y. Zhang, J. Feng et al., “Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4,” International Journal of Nanomedicine, vol. 8, pp. 1141–1154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Meng, K. Xu, Y. Xu et al., “Nanocapsules based on mPEGylated artesunate prodrug and its cytotoxicity,” Colloids and Surfaces B: Biointerfaces, vol. 115, pp. 164–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Yang, W.-S. Shim, F.-D. Cui et al., “Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor,” International Journal of Pharmaceutics, vol. 371, no. 1-2, pp. 142–147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Guo and R. A. Gemeinhart, “Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 70, no. 2, pp. 597–604, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bulmer, A. Margaritis, and A. Xenocostas, “Production and characterization of novel chitosan nanoparticles for controlled release of rHu-erythropoietin,” Biochemical Engineering Journal, vol. 68, pp. 61–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Fan, W. Yan, Z. Xu, and H. Ni, “Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique,” Colloids and Surfaces B: Biointerfaces, vol. 90, no. 1, pp. 21–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Mattheolabakis, B. Rigas, and P. P. Constantinides, “Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives,” Nanomedicine, vol. 7, no. 10, pp. 1577–1590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-Z. Du, L. Wang, H. Yuan, X.-H. Wei, and F.-Q. Hu, “Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin,” Colloids and Surfaces B: Biointerfaces, vol. 69, no. 2, pp. 257–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Eriksson, E. Johansson, N. Kettaneh-Wold, C. Wikström, and S. Wold, Design of Experiments: Principles and Applications, Umetrics, Umeå Learnways AB, Stockholm, Sweden, 2000.
  26. P. Mukhopadhyay, K. Sarkar, S. Bhattacharya, A. Bhattacharyya, R. Mishra, and P. P. Kundu, “pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery,” Carbohydrate Polymers, vol. 112, pp. 627–637, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Tahara, H. Yamamoto, N. Hirashima, and Y. Kawashima, “Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 74, no. 3, pp. 421–426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Lee, J. S. Choi, I. Kim et al., “Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes,” International Journal of Nanomedicine, vol. 8, pp. 2975–2983, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Zhao, Y. Zhang, X. Zhang et al., “Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 4609–4619, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Abdelwahed, G. Degobert, S. Stainmesse, and H. Fessi, “Freeze-drying of nanoparticles: formulation, process and storage considerations,” Advanced Drug Delivery Reviews, vol. 58, no. 15, pp. 1688–1713, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Bozdag, K. Dillen, J. Vandervoort, and A. Ludwig, “The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles,” Journal of Pharmacy and Pharmacology, vol. 57, no. 6, pp. 699–707, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. T. H. Tran, T. D. Nguyen, B. K. Poudel et al., “Development and evaluation of artesunate-loaded chitosan-coated lipid nanocapsule as a potential drug delivery system against breast cancer,” AAPS PharmSciTech, 2015. View at Publisher · View at Google Scholar
  33. Y.-I. Chung, J. C. Kim, Y. H. Kim et al., “The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting,” Journal of Controlled Release, vol. 143, no. 3, pp. 374–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. Y.-Y. Lu, T.-S. Chen, J.-L. Qu, W.-L. Pan, L. Sun, and X.-B. Wei, “Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells,” Journal of Biomedical Science, vol. 16, article 16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. P. C. H. Li, E. Lam, W. P. Roos, M. Z. Zdzienicka, B. Kaina, and T. Efferth, “Artesunate derived from traditional Chinese medicine induces DNA damage and repair,” Cancer Research, vol. 68, no. 11, pp. 4347–4351, 2008. View at Publisher · View at Google Scholar · View at Scopus